Charles Schwab
AGN

Charles Schwab’s Allergan plc AGN Stock Holding History

Charles Schwab’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,453,924
Closed -$257M – 3418
2020
Q1 		$257M Buy
1,453,924
+20,946
+1% +$3.94M 0.15% 134
2019
Q4 		$274M Buy
1,432,978
+23,936
+2% +$4.32M 0.15% 124
2019
Q3 		$237M Buy
1,409,042
+86,692
+7% +$14.1M 0.14% 137
2019
Q2 		$221M Sell
1,322,350
-28,988
-2% -$4.01M 0.13% 137
2019
Q1 		$198M Buy
1,351,338
+20,811
+2% +$3.02M 0.13% 148
2018
Q4 		$178M Buy
1,330,527
+42,622
+3% +$6.99M 0.14% 138
2018
Q3 		$245M Buy
1,287,905
+6,375
+0.5% +$1.17M 0.16% 109
2018
Q2 		$214M Buy
1,281,530
+61,029
+5% +$9.8M 0.16% 120
2018
Q1 		$205M Buy
1,220,501
+31,839
+3% +$5.34M 0.16% 120
2017
Q4 		$194M Buy
1,188,662
+48,352
+4% +$8.68M 0.15% 125
2017
Q3 		$234M Buy
1,140,310
+70,492
+7% +$16.4M 0.2% 87
2017
Q2 		$260M Buy
1,069,818
+55,747
+5% +$13.1M 0.24% 71
2017
Q1 		$242M Sell
1,014,071
-68,213
-6% -$15.9M 0.24% 69
2016
Q4 		$227M Sell
1,082,284
-63,348
-6% -$13.1M 0.25% 64
2016
Q3 		$264M Buy
1,145,632
+21,101
+2% +$5.16M 0.31% 49
2016
Q2 		$260M Buy
1,124,531
+28,003
+3% +$6.46M 0.33% 49
2016
Q1 		$294M Buy
1,096,528
+26,650
+2% +$7.63M 0.39% 44
2015
Q4 		$334M Buy
1,069,878
+40,665
+4% +$12.1M 0.45% 37
2015
Q3 		$280M Buy
1,029,213
+15,298
+2% +$4.7M 0.41% 44
2015
Q2 		$308M Buy
1,013,915
+16,639
+2% +$4.96M 0.42% 41
2015
Q1 		$297M Buy
997,276
+346,335
+53% +$98.7M 0.42% 45
2014
Q4 		$168M Buy
650,941
+79,119
+14% +$19.8M 0.25% 78
2014
Q3 		$138M Buy
571,822
+196,660
+52% +$44M 0.23% 83
2014
Q2 		$83.7M Sell
375,162
-47,033
-11% -$9.74M 0.14% 151
2014
Q1 		$86.9M Buy
422,195
+23,240
+6% +$4.6M 0.16% 128
2013
Q4 		$67M Buy
+398,955
New +$62.4M 0.13% 159
2013
Q3 		– Sell
-245,115
Closed -$30.7M – 3076
2013
Q2 		$30.7M Buy
+245,115
New +$27.8M 0.07% 275

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Charles Schwab's AGN Position: Q2 2020 in Review

Charles Schwab sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,453,924 shares — an estimated $257M sold.

Charles Schwab first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $334M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Charles Schwab reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Charles Schwab sold 1,453,924 Allergan plc shares in Q2 2020, an estimated $257M.
  • Charles Schwab first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Charles Schwab's Allergan plc position peaked at $334M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.